The rapidly evolving field of Geographic Atrophy, with Prof. Robyn Gymer

Spurred on by the seemingly hopeless plight of patients with AMD, professor Robyn Gymer is one of the leading lights in dry AMD research. Robyn explains why it was important to have developed a universally accepted classification for GA, the relationships between macular structure and function, and why early OCT signs of nascent GA can help us identify who is at risk of progression. She also explores the potential role of complement blockers and gene therapy in slowing the progression of GA.This episode is a perfect way to get up to speed with the rapidly evolving field of GA, a condition with which 60 million people globally will suffer by 2040.Plus Robyn regales us with a wonderful anecdote about her first Moorfields clinic with Professor Bird, when her rather direct Antipodean manner left the other British trainees open-mouthed!You can hear more from Robyn in our subscriber episode, including the crucial role of nutrition and diet in the aetiology of AMD. You can get full access to Eyes On Tomorrow, including:* Monthly bonus conversations from our guests  * PDFs of reading material  linked to topics discussed in the podcast and perfect for your CPD* Summaries of the key learnings as a regular newsletter* Discussion with other subscribersAll for just £25 per year, when you subscribe at eyesontomorrow.substack.com/subscribeProduced by Daisy Chakoo at Rethink Audio. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit eyesontomorrow.substack.com/subscribe

There are no comments yet.

Please log in to write the first comment.